Alpha Tau Medical Reports Q1 2025 Results
Ticker: DRTSW · Form: 6-K · Filed: May 19, 2025 · CIK: 1871321
| Field | Detail |
|---|---|
| Company | Alpha Tau Medical Ltd. (DRTSW) |
| Form Type | 6-K |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, corporate-update, sec-filing
TL;DR
Alpha Tau Medical dropped its Q1 2025 earnings report on 5/19.
AI Summary
On May 19, 2025, Alpha Tau Medical Ltd. announced its first quarter 2025 financial results and provided a corporate update. The company filed a Form 6-K to report this information, attaching the press release as Exhibit 99.1. This filing is incorporated by reference into several of the company's existing Form F-3 registration statements.
Why It Matters
This filing provides investors with the latest financial performance and corporate developments for Alpha Tau Medical, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial results filing and does not introduce new risks.
Key Players & Entities
- Alpha Tau Medical Ltd. (company) — Registrant
- May 19, 2025 (date) — Date of press release and filing
- Exhibit 99.1 (document) — Attached press release
- Form F-3 (document) — Registration statements
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report Alpha Tau Medical Ltd.'s first quarter 2025 financial results and provide a corporate update, as detailed in an attached press release.
When was the press release announcing the Q1 2025 results issued?
The press release was issued on May 19, 2025.
What exhibit is attached to this Form 6-K?
Exhibit 99.1, which is the press release titled 'Alpha Tau Medical Announces First Quarter 2025 Financial Results and Provides Corporate Update,' is attached to this Form 6-K.
Which registration statements does this filing get incorporated into?
This Report and its exhibits are incorporated by reference into the Company's Registration Statements on Form F-3, specifically File Nos. 333-271073, 333-264306, and 333-274457.
What is Alpha Tau Medical Ltd.'s principal executive office address?
Alpha Tau Medical Ltd.'s principal executive offices are located at Kiryat HaMada St. 5, Jerusalem, Israel, 9777605.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 19, 2025 regarding Alpha Tau Medical Ltd. (DRTSW).